Literature DB >> 10562879

A cardiovascular extension of the Health Measurement Questionnaire.

A J Martin1, P P Glasziou, R J Simes.   

Abstract

OBJECTIVE: To investigate the psychometric properties of a cardiovascular extension of an existing utility-based quality of life questionnaire (Health Measurement Questionnaire). The new instrument has been named the Utility Based Quality of life--Heart questionnaire, or UBQ-H.
DESIGN: Explored the test-retest reliability, construct validity, and responsiveness of the UBQ-H. PATIENTS: A sample of 322 patients attending cardiac outpatient clinics were recruited from two large metropolitan teaching hospitals. A second sample of 1112 patients taking part in the LIPID trial was also used to investigate the validity and responsiveness of the UBQ-H.
RESULTS: Ninety per cent of all UBQ-H questionnaires were returned, and item completion rates were high (median of less than 1% missing or N/A answers). Cronbach's alpha measure of internal consistency for the scales ranged between 0.79-0.91, and each item was also most strongly correlated with its hypothesised domain than alternative domains. The intra-class test-retest reliability of the UBQ-H scales ranged from 0.65 to 0.81 for patients with stable health. Results supported the construct validity of the UBQ-H. The UBQ-H was significantly correlated with other information on quality of life (for example, General Health Questionnaire) as anticipated. The instrument was able to distinguish between contrasted groups of patients (for example, with versus without symptoms of dyspnoea, prior myocardial infarction versus none, etc), and was responsive to changes in health associated with adverse events requiring hospitalisation.
CONCLUSIONS: The modifications made to the Health Measurement Questionnaire has resulted in an assessment designed for cardiovascular patients that has proved to be both reliable and valid.

Entities:  

Mesh:

Year:  1999        PMID: 10562879      PMCID: PMC1756955          DOI: 10.1136/jech.53.9.548

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  16 in total

Review 1.  Multi-attribute preference functions. Health Utilities Index.

Authors:  G W Torrance; W Furlong; D Feeny; M Boyle
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981

Review 2.  Quality of life end points in cancer clinical trials: review and recommendations.

Authors:  C M Moinpour; P Feigl; B Metch; K A Hayden; F L Meyskens; J Crowley
Journal:  J Natl Cancer Inst       Date:  1989-04-05       Impact factor: 13.506

3.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

4.  Quality-of-life improvement compared after hip and knee replacement.

Authors:  F H Norman-Taylor; C R Palmer; R N Villar
Journal:  J Bone Joint Surg Br       Date:  1996-01

5.  Measuring health status: a new tool for clinicians and epidemiologists.

Authors:  S M Hunt; J McEwen; S P McKenna
Journal:  J R Coll Gen Pract       Date:  1985-04

6.  Quality of life six months after myocardial infarction treated with thrombolytic therapy. AUS-TASK Group. Australian arm of International tPA/SK Mortality Trial.

Authors:  P P Glasziou; S Bromwich; R J Simes
Journal:  Med J Aust       Date:  1994-11-07       Impact factor: 7.738

7.  The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups.

Authors:  C A McHorney; J E Ware; J F Lu; C D Sherbourne
Journal:  Med Care       Date:  1994-01       Impact factor: 2.983

8.  Quality of life in the first 100 days after suspected acute myocardial infarction--a suitable trial endpoint?

Authors:  J Rawles; J Light; M Watt
Journal:  J Epidemiol Community Health       Date:  1992-12       Impact factor: 3.710

9.  Design features and baseline characteristics of the LIPID (Long-Term Intervention with Pravastatin in Ischemic Disease) Study: a randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris.

Authors: 
Journal:  Am J Cardiol       Date:  1995-09-01       Impact factor: 2.778

10.  Measuring health status in the community: a comparison of methods.

Authors:  P Kind; C M Gudex
Journal:  J Epidemiol Community Health       Date:  1994-02       Impact factor: 3.710

View more
  4 in total

1.  Valuation of depression co-occurring with a somatic condition: feasibility of the time trade-off task.

Authors:  Katerina Papageorgiou; Karin M Vermeulen; Fenna R M Leijten; Erik Buskens; Adelita V Ranchor; Maya J Schroevers
Journal:  Health Expect       Date:  2014-11-13       Impact factor: 3.377

2.  Economic evaluation of cinacalcet in the treatment of secondary hyperparathyroidism in Italy.

Authors:  Mario Eandi; Lorenzo Pradelli; Sergio Iannazzo; Silvia Chiroli; Giuseppe Pontoriero
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 3.  Cost-Effectiveness of Cardiac Rehabilitation in Patients with Coronary Artery Disease: A Meta-Analysis.

Authors:  Tomoyuki Takura; Nozomi Ebata-Kogure; Yoichi Goto; Masahiro Kohzuki; Masatoshi Nagayama; Keiko Oikawa; Teruyuki Koyama; Haruki Itoh
Journal:  Cardiol Res Pract       Date:  2019-06-04       Impact factor: 1.866

4.  Implementation and prospective evaluation of the Country Heart Attack Prevention model of care to improve attendance and completion of cardiac rehabilitation for patients with cardiovascular diseases living in rural Australia: a study protocol.

Authors:  Alline Beleigoli; Stephen J Nicholls; Alex Brown; Derek P Chew; John Beltrame; Anthony Maeder; Carol Maher; Vincent L Versace; Jeroen M Hendriks; Philip Tideman; Billingsley Kaambwa; Christopher Zeitz; Ivanka J Prichard; Rosanna Tavella; Rosy Tirimacco; Wendy Keech; Carolyn Astley; Kay Govin; Katie Nesbitt; Huiyun Du; Stephanie Champion; Maria Alejandra Pinero de Plaza; Imelda Lynch; Vanessa Poulsen; Marie Ludlow; Ken Wanguhu; Hendrika Meyer; Ali Krollig; Lemlem Gebremichael; Chloe Green; Robyn A Clark
Journal:  BMJ Open       Date:  2022-02-16       Impact factor: 3.006

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.